Jan
2010

The effect of the suspension of the license for aprotinin on the care of patients undergoing cardiac surgery: a survey of cardiac anesthesiologists and surgeons opinions in the United Kingdom.

McMullan V, Alston RP
J Cardiothorac Vasc Anesth 2010; Jan 5 [Epub ahead of print].
NATA Rating :
Review by : J.-F. Hardy
NATA Review

The authors report the results of a survey of UK cardiac anesthesiologists and surgeons on the effect of the withdrawal of aprotinin from clinical practice. The majority of respondents felt that suspension of aprotinin’s license had had no effect while a third felt it had impacted negatively on patient care. Given the biases involved, this survey presents little useful information for clinicians.

– Jean-Franois Hardy